Trial Profile

An Exploratory Study to Evaluate the Efficacy and Safety of TYNADOTE Combined N-acetylcysteine in the Treatment of Acetaminophen Overdose

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 13 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Acetylcysteine (Primary) ; SNP 820 (Primary)
Indications Liver disorders
Focus Therapeutic Use
Sponsors Sinew Pharma

Most Recent Events

09 Jan 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2026.
09 Jan 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2026.
14 Apr 2023 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Dec 2022 to 1 May 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com